Universal API Implementation Guide - Local Development build (v1.1.20) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
Release 2025 Jan 31
Itovebi
- Access Solutions/Patient Foundation (AS/GPF) enrollments via UAPI is available for Itovebi as of 1/31/2025.
- BioOncology Prescriber Service Form (PSF) version M-US-00019768(v3.0)(2024) will be valid until 03/14/2025.
- BioOncology Prescriber Service Form (PSF) version M-US-00019768(v4.0)(2024) can be accessed on the Access Solutions website
- FDA approved indications (ICD10 codes) can be found on the Access Solutions website for Itovebi
- Itovebi available prescriptions are listed on the AS/GPF - Products Specific page
Itovebi AS/GPF Enrollment - Questionnaires
Questionnaires for Access Solutions/Patient Foundation enrollments can be accessed by requesting Itovebi questionnaire definitions from the Genentech FHIR Server.
- URL to AS/GPF Questionnaire endpoint (test): https://test-us-e1.apis.roche.com/pharma-cmg-ehr-fhir-exp-test/v2/questionnaire?name=Itovebi
- URL to AS/GPF Questionnaire endpoint (stage): https://stage-us-e1.apis.roche.com/pharma-cmg-ehr-fhir-exp-stage/v2/questionnaire?name=Itovebi
- URL to AS/GPF Questionnaire endpoint (prod): https://prod-us-e1.apis.roche.com/pharma-cmg-ehr-fhir-exp/v2/questionnaire?name=Itovebi
Questionnaire Update - Copay Terms & Conditions
The Copay terms and conditions for drug & admin programs have been updated as of 1/31/25.
Type |
Available in QA (test) environment? |
Product(s) impacted |
linkId impacted (if applicable) |
Comments |
Update |
Yes |
All products |
agree-to-copay-program-terms |
Updated verbiage indicated on the Copay Eligibility Questions page in red |
Update |
Yes |
Products with admin programs |
agree-to-admin-copay-program-terms |
Updated verbiage indicated on the Copay Eligibility Questions page in red |